111, Inc. enters direct supply partnership with Beijing Scrianen Pharmaceutical

111, Inc. announced that the company has entered into a strategic direct supply partnership with Beijing Scrianen Pharmaceutical, a pharmaceutical enterprise that integrates research and development, production and marketing. The signing ceremony of the partnership was attended by Gang Yu, co-founder and executive chairman of 111, Bin Yi, chairman of Scrianen, and senior management teams from both companies. This new agreement aims to enhance their existing collaboration, focusing on a range of products including “Scrianen Folic Acid Tablets” for nationwide distribution.